EU could pay over $10 billion for Pfizer, CureVac vaccines – source
The European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfizer-BioNTech and CureVac, an EU official involved…
COVID-19: Pfizer-BioNTech vaccine deliveries could begin Dec.
Pfizer Inc and BioNTech could secure emergency U.S. and European authorization for their COVID-19 vaccine next month after final trial results showed it had a 95% success rate and no…
COVID-19: WHO working to ensure fair vaccine distribution, says first use not expected until early 2021
Researchers are making “good progress” in developing vaccines against COVID-19, with a handful in late-stage trials, but their first use cannot be expected until early 2021, a World Health Organization…
COVID-19: Wave of promising study results raises hope for vaccines
Early data from trials of three potential COVID-19 vaccines released on Monday, including a closely-watched candidate from Oxford University, increased confidence that a vaccine can train the immune system to…